Education News and Research

RSS

ARRA's legacies may solve challenges related to health, energy and environment

The presidents of six leading research universities and two higher-education associations joined Vice President Joe Biden and White House science advisor Dr. John Holdren this morning to discuss the scientific research and related activities that have been made possible by the American Recovery and Reinvestment Act (ARRA).

22 Sep 2010

Study demonstrates why targeted therapies do not work in majority of people

In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling "network" makes a cancer cell resistant to a drug and selectively target them as well, say researchers at Georgetown Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center.

22 Sep 2010

Study: New percutaneous mitral valve clip offers marked clinical benefit

A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation, according to a study presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

22 Sep 2010

Specific orofacial characteristics can lead to accurate diagnosis of fetal alcohol spectrum disorders

Fetal alcohol spectrum disorders (FASD) is an umbrella term that describes the range of effects that can occur in a person whose mother drank alcohol while pregnant. Each year, FASD affect an estimated 40,000 infants in the United States—more than spina bifida, Down syndrome, and muscular dystrophy combined.

22 Sep 2010

Study: Doctors who are overweight or lack training are reluctant to counsel patients about diet, exercise

Physician's confidence in their abilities to counsel patients on a healthy diet and exercise may be related to their own personal habits, according to a study by the University of Michigan Cardiovascular Center.

22 Sep 2010

First free-standing infectious disease hospital built in US in over 50 years

Many Americans think tuberculosis (TB) has been eliminated in this country. But, while it is no longer as common or deadly as it was decades ago, it is estimated that more than a third of the world's population is infected with the disease. The new Texas Center for Infectious Disease (TCID) hospital was designed to provide patients with the care and treatment needed to help curb the resurgence of TB in the United States and reduce the drug-resistance of strains developing worldwide.

22 Sep 2010

Clinton Global Initiative meeting kicks off, U.S. will commit to Clean Cookstove project

"World leaders, CEOs, non-governmental organizations and philanthropists" are gathering this week at the Clinton Global Initiative (CGI) annual meeting, "[t]imed to coincide with the beginning of the United Nations General Assembly," WNYC News reports (Herman, 9/20).

22 Sep 2010

Republicans plan to chip away at health law; Senators call for insurance rate hearings

The New York Times: Republicans are hopeful they can pick up enough seats in November's midterm elections to chip away at the new health law. "This goal, though not fleshed out in a detailed legislative proposal, is much more than a campaign slogan. That conclusion emerged from interviews with a wide range of Republican lawmakers, who said they were determined to chip away at the law if they could not dismantle it." Republicans are expected to release specifics of the plan Thursday.

22 Sep 2010

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment - an emerging field of research that could revolutionize medicine by creating "smart cells" to deliver medications and other therapeutics more effectively.

22 Sep 2010

High dose aspirin effective for treatment of severe headache and migraine

An inexpensive, hundred-year-old therapy for pain - aspirin - is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center. Study participants were administered aspirin through an IV and 25 percent of the time they reported a significant reduction in pain - three points on the 10-point pain scale.

22 Sep 2010

Biodegradable polymers represent future of stent design

Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

21 Sep 2010

Greenway announces advanced allergy module in integrated EHR solution

Greenway Medical Technologies, Inc. today announced the most advanced allergy module available in an integrated electronic health record (EHR) solution for ear, nose and throat (ENT) and allergy physician practices. Developed in conjunction with a leading ENT and allergy testing and treatment practice, the Greenway® Allergy Module for PrimeSuite® provides unmatched allergy testing, serum creation, allergy shot record, lot maintenance and reporting functionality for today's ENT and allergy practice groups.

21 Sep 2010

Volcano to end distribution agreement with Fukuda Desnhi in Japan

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has reached an agreement with Fukuda Desnhi Co., Ltd. to end its distribution agreement in Japan.

21 Sep 2010

National survey highlights need for greater awareness on lymphoma

While general awareness of lymphoma remains high, a new survey released today by the Lymphoma Research Foundation (LRF) reveals significant knowledge gaps among Americans about the disease, which is the most prevalent form of blood cancer in the United States. Survey results showed a high number of adults (86 percent) remain unaware that there are 67 different types of lymphoma - 61 types of non-Hodgkin lymphoma and six types of Hodgkin lymphoma.

21 Sep 2010

NIDA awards 5-year, $3.7M research grant for development of drug to treat cocaine addiction

The University of Maryland School of Pharmacy has received a prestigious $3.7 million grant to develop a drug to treat cocaine addiction based on an active ingredient found in some Chinese prescription medicines.

21 Sep 2010

Cook Medical sponsors sessions to reduce risk of CRBSI infections

At the 24th Annual Scientific Meeting of the Association for Vascular Access (AVA), Cook Medical continues its dedication to educating medical communities on advancements in procedures and technologies. Cook will sponsor two sessions that examine how to combine process and technology to reduce the risk of dangerous catheter-related bloodstream infections (CRBSIs).

21 Sep 2010

USAID, GAIN announce $1 million to reduce malnutrition burden

The United States Agency for International Development (USAID) and the Global Alliance for Improved Nutrition (GAIN) announced today $1 million to expand efforts to reduce the growing burden of malnutrition. The announcement will be made today at a historic gathering of the First Ladies of Africa, who convened to declare nutrition as a critical priority for eliminating poverty, improving health and advancing food security in their nations.

21 Sep 2010

Young victims of cyber bullying more likely to suffer from depression

Young victims of electronic or cyber bullying — which occurs online or by cell phone — are more likely to suffer from depression than their tormentors are, a new study finds.

21 Sep 2010

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the GRACE study enrolled 67 percent women, demonstrating that it is possible to recruit large numbers of women into U.S.-based HIV treatment studies.

21 Sep 2010

Study reveals molecular steps for pneumonia therapy

A structural molecule and the cellular pump that regulates its levels influence the severity of pneumonia and could provide new ways of treating the lung infection, which is a leading cause of hospitalization and death, according to scientists at the University of Pittsburgh and the University of Iowa. Their findings are available online in Nature Medicine.

21 Sep 2010